Brinces, Marissa Z.
HRN: 22-99-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/06/2023
05/12/2023
IV
3.375g
Q6
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes